RNU6-139P

Across TCGA pan-cancer cohorts, RNU6-139P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RNU6-139P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-139P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-139P expression acts as an unfavorable survival marker.

KIRC, HNSC, and TGCT are the cancer types where RNU6-139P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.100	0.881	<.001	144	view →
HNSC	OS	Tertile	All	0.057	0.768	<.001	144	view →
TGCT	OS	Tertile	III,IV	0.003	1.000	<.001	108	view →
STAD	OS	Tertile	II,III,IV	0.161	0.560	.003	54	view →
MESO	DFS	Tertile	III,IV	0.082	0.414	.007	54	view →
SKCM	DFS	Tertile	All	0.058	0.757	<.001	45	view →
BRCA	DFS	Tertile	All	0.474	0.904	<.001	36	view →
LIHC	OS	Tertile	All	0.098	0.777	<.001	36	view →
ESCA	OS	Tertile	All	0.195	0.684	.001	27	view →
GBM	OS	Tertile	All	0.152	0.420	.048	9	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RNU6-139P–KIRC (OS)

Open the KIRC breakdown →